Clinical Immunology, Neuropharmacology and Drug Development

Gene Therapy and CRISPR in Neuroimmunology

This track focuses on the emerging role of gene therapy and CRISPR technology in treating neuroimmune disorders. Researchers are encouraged to submit abstracts on the development and application of gene-editing tools for correcting genetic mutations, modulating immune responses, and developing long-term treatments for neurological diseases. Attendees will gain insights into the latest advancements in gene therapy, including clinical trials and regulatory challenges, as well as the potential for CRISPR to revolutionize the treatment landscape for neuroimmunological conditions.